Hemato-Oncology Hemato-Oncology November 7, 2024 Posted by myadmin 28 Dec An open-label, phase 2 trial of Nanatinostat in combination with valganciclovir in patients with Epstein-Barr virus-positive (EBV+) r...Continue reading
